Click to Enlarge
Facebook
Twitter
The Oxford-AstraZeneca Covid vaccine could offer longer-lasting immunity than other jabs, the Daily Telegraph reports. The paper says AstraZeneca is preparing to release new research on the jab’s impact on T-cell immunity which it says could continue after antibodies wane. The paper says the development could explain why European countries are suffering a surge in infections yet to strike the UK.